---
figid: PMC10341681__ijms-24-10505-g003
pmcid: PMC10341681
image_filename: PMC10341681__ijms-24-10505-g003.jpg
figure_link: /pmc/articles/PMC10341681/figure/F3/
number: Figure 3
figure_title: The signaling pathways and targets of saponin-regulated tau protein
  phosphorylation.
caption: The signaling pathways and targets of saponin-regulated tau protein phosphorylation.
  (1). PF11 and xanthoperidinol, regulate targets of LCMT-1/PP2A signaling pathways;
  (2). PF11, regulates targets of IRS-1/P13K/Akt/GSK-3β and calpain I/CDK5 signaling
  pathways; (3). Ginsenoside Rb1 and Ginsenoside Rd, regulate the activity of PP2A;
  (4). Theasaponin E1, inhibits tau protein phosphorylation by regulating GSK-3β,
  CDK5, c-Jun JNK, MAPK, ERK1/MARK, and PP2A; (5). Xanthoceraside, regulates the activity
  of GSK-3β. The above-mentioned saponins inhibit tau protein phosphorylation by modulating
  the targets of these signaling pathways
article_title: 'Therapeutic Candidates for Alzheimer’s Disease: Saponins'
citation: Ruifeng Zhang, et al. Int J Mol Sci. 2023 Jul;24(13).
year: '2023'
pub_date: 2023-7-
epub_date: 2023-6-22
doi: 10.3390/ijms241310505
journal_title: International Journal of Molecular Sciences
journa_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords:
- Alzheimer’s disease
- saponin
- amyloid beta
- inflammation
- oxidative stress
- apoptosis
---
